Protein may play role in obesity, diabetes, aging

February 15, 2012 By Michael C. Purdy, Washington University School of Medicine in St. Louis

(Medical Xpress) -- Researchers at Washington University School of Medicine in St. Louis have identified a potent regulator of sensitivity to insulin, the hormone that controls blood sugar levels. The new findings may help scientists find better treatments for type 2 diabetes, obesity and other health problems caused by the body’s inability to properly regulate blood sugar.
 
The research is published online Feb. 13 in PLoS ONE.

Fat and muscle in patients with become resistant to insulin, which normally causes them to take in glucose from the blood. The protein studied by the researchers, known as TBC1D3, keeps the insulin pathway open, so the cells can continue to take up glucose. TBC1D3 is found only in humans and certain other primates.

“When cells made more of the TBC1D3 protein, they had a much bigger response to insulin,” says senior author Philip Stahl, PhD, professor of cell biology and physiology. “We found that TBC1D3 significantly slows the deactivation of a molecule that relays signals from the insulin receptor. This enhances the cells’ response to insulin.”

Stahl studies G proteins, which help convert signals from hormones like insulin into specific actions within cells. He became interested in TBC1D3 because part of it binds to some G proteins.

In the new study, Stahl and his colleagues showed that higher levels of TBC1D3 impede a feedback loop that normally deactivates the insulin signal into the cell from receptors on the cell membrane.

“There are quite a few regulatory pathways like this in biology,” Stahl says. “To make sure the signal doesn’t stay on indefinitely, there are factors built into the signaling pathway that reach back to the origin of the signal and attempt to shut it off.”

More active TBC1D3 impedes that feedback process, keeping the insulin signaling pathway turned on longer, Stahl explains.

Stahl and his colleagues tracked the effects of TBC1D3 to a cluster of proteins that control some of the cell’s most important functions, including nutrient uptake, cell growth and proliferation, and aging.

“We found that TBC1D3 activates a protein called PP2A,” Stahl says. “Flies had shorter lifespans when the PP2A gene was knocked out. This suggests that TBC1D3 also may influence the aging process.”

The researchers are now investigating the factors that regulate the activity of TBC1D3. One such influence may be the number of copies of the TBC1D3 gene in a person’s DNA.

TBC1D3 is one of the most duplicated genes in humans, appearing anywhere from five to more than 50 times in an individual’s DNA. The scientists plan to compare cells with many copies of the gene to others with fewer copies to see whether the number of copies is linked to changes in the cells’ response to .

Explore further: It takes a sugar to catch a sugar

More information: Wainszelbaum MJ, Liu J, Kong C, Srikanth P, Samovski D, Su X, Stahl PD. TBC1D3, a hominoid-specific gene, delays IRS-1 degradation and promotes insulin signaling by modulating p70 S6 kinase activity. PLoS ONE, online Feb. 13, 2012.

Related Stories

It takes a sugar to catch a sugar

December 2, 2011
After every meal, the hormone insulin is released into the bloodstream, issuing instructions to target cells to begin taking up excess sugar. In some situations, however, cells stop responding to these signals; and this insulin-resistant ...

Pig to primate transplants show promise for diabetes

November 9, 2011
(Medical Xpress) -- Scientists exploring a potential cure for diabetes have shown that transplanting insulin-producing cells from embryonic pigs into diabetic monkeys can dramatically lower blood sugar levels, though not ...

Scientists find missing link in regulation of glucose

December 22, 2011
(Medical Xpress) -- A team led by USC neuroscientist Alan Watts identified for the first time a biochemical signal that helps regulate the amount of glucose in the blood.

Unearthing a path leading to diabetes

January 6, 2012
A molecular mechanism that links diet, obesity and diabetes involves depletion of specialized ‘transporter proteins’, a Japanese–American team has found. Transporter proteins deliver glucose to so-called ‘beta ...

Insulin signaling is distorted in pancreases of Type 2 diabetics

December 13, 2011
Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells — the cells that produce insulin.

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.